Hemi Health raises €4 million for global expansion
Female-led Danish startup Hemi Health has secured a €4 million funding round to accelerate the international rollout of its digital platform for managing migraine and concussion-related conditions. The fresh capital will support product development, clinical validation and entry into new European and North American markets, as demand for tech-enabled neurological care continues to rise.
Targeting a major gap in neurological care
Hemi Health focuses on patients suffering from chronic migraine and lingering symptoms following concussion, areas where traditional healthcare systems often struggle to provide continuous, personalized follow-up. The company’s solution combines remote monitoring, structured symptom tracking and evidence-based care pathways designed in collaboration with neurologists and rehabilitation specialists.
Through a user-friendly app, patients can log pain episodes, triggers, medication use and cognitive issues, while clinicians gain access to real-time dashboards that support more precise diagnosis and treatment adjustments. By digitizing this workflow, Hemi Health aims to shorten waiting times, reduce misdiagnosis and improve long-term outcomes for patients who are frequently under-served.
Female-led founding team and clinical focus
The startup is led by a female founding team with backgrounds in digital health, neurology and clinical research. This combination allows Hemi Health to design tools that meet strict medical standards while remaining accessible to patients and clinicians. The company is working with hospitals and specialist clinics to integrate its platform into existing care pathways and to generate robust clinical data.
Scaling internationally in a growing digital health market
The new €4 million injection will be directed toward scaling infrastructure, meeting regulatory requirements in new regions and expanding partnerships with healthcare providers and insurers. With the global burden of neurological disorders increasing and health systems under pressure, investors see strong potential in specialized digital therapeutics that can complement traditional in-person care.
By focusing on migraine and concussion—two conditions that are common, debilitating and often poorly managed—Hemi Health is positioning itself as a key player in the next generation of technology-driven neurological care.